Capital Group Private Markets - aVenture Asset Manager Research
Location
Beijing, CN
Founded
1992
Capital Group Private Markets is a global leader in emerging markets private equity, having been established in 1992. The firm focuses on investing in diverse sectors across global emerging markets, including Latin America, with a particular emphasis on Colombia. They typically engage in later-stage investments such as Series C and Series E rounds, having invested over $5 billion in more than 80 companies through their six emerging markets private equity funds.
Notable portfolio companies include Innovent Biologics, which has raised $150 million. The firm's investment philosophy centers on building a diversified portfolio across various emerging markets. Capital Group Private Markets is known for its deep expertise and long-term commitment to these regions, offering unique value-add services such as strategic guidance and leveraging their extensive network to support portfolio companies' growth.
Capital Group Private Markets - Portfolio Snapshot
Portfolio activity breakdown across disclosed investments and stages
Portfolio Companies2
Current Portfolio Count2
Top Investment Stages
Series C1 (50.0%)
Series E1 (50.0%)
Stage Mix
Series C 50%Series E 50%
Concentration shown as share of disclosed investments by stage.